2/8/2021 12:07:11 AM
Ocugen Announces 3 Mln Registered Direct Offering Of Common Stock Priced At A Premium To Market At $7.65/Shr
12/23/2020 9:03:48 PM
Ocugen Forms Vaccine Advisory Board To Evaluate Clinical And Regulatory Path To Approval In US Market Of COVAXIN
12/22/2020 7:46:31 AM
Ocugen, Bharat Biotech Sign Binding LOI To Co-develop COVID-19 Vaccine Candidate, COVAXIN